Navigation Links
VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
Date:11/17/2009

MOUNTAIN VIEW, Calif., Nov. 17 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) plans to announce the results from the avanafil REVIVE (TA-301) phase 3 clinical trial on November 18th prior to market open. The announcement will be followed by a webcast and conference call at 8:30 a.m. Eastern time.

Conference Call Information

Domestic callers: 1-800-776-0853

International callers: 1-913-312-0980

Webcast information: http://ir.vivus.com. A webcast replay will be available on the VIVUS web site for 30 days.

About VIVUS

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa(TM), has recently completed phase 3 clinical trials for the treatment of obesity. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE® (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com.

    CONTACT:

    VIVUS, Inc.                Investor Relations:  The Trout Group
    Timothy E. Morris                               Brian Korb
    Chief Financial Officer                         646-378-2923
    650-934-5200

                                  Media Relations:  Pure Communications, Inc.
             
'/>"/>
SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 Major pharmaceutical and medical ... a legal conference in Philadelphia on ... issues, Tom Hagy of HB Litigation Conferences has ... visit HB,s website at http://litigationconferences.com/?p=31886 The ... McCambridge Singer & Mahoney and Michelle Hart Yeary ...
(Date:8/27/2015)... Aug. 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first ... the United States in a trial ... stent for blockages in the main artery of the leg. ... and potentially less risk for stent fracture or re-narrowing after ... single-arm, multicenter clinical trial of the BioMimics 3D Stent System ...
(Date:8/27/2015)... 27, 2015 The Elekta Linac-based ... Boston on July 9th for its ... to more fully exploit the potential of advances in ... diseases. "As an established provider of sophisticated ... assume a leadership role - in collaboration with its ...
Breaking Medicine Technology:Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3First Pennsylvania Patient Treated in Landmark Vascular Study 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3
(Date:8/27/2015)... ... ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open ... will be located at US Highway 19 North and Highlands Boulevard, less than eight miles ... on the project is slated to begin in September 2015. , The new ...
(Date:8/27/2015)... ... August 27, 2015 , ... King Kullen, America’s First Supermarket, is celebrating 85 ... Cullen in 1930 and recognized by the Smithsonian Institute as America’s First Supermarket, King ... operated, the Cullen & Kennedy families have created a culture of caring while building ...
(Date:8/27/2015)... ... 2015 , ... Since its launch on August 16, 2007, ... in three counties, LA, Orange and San Bernardino. Their twenty physicians have ... Dr. Richy Agajanian, the Oncology Institute of Hope and Innovation is dedicated to ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... solutions for drugs, biologics and consumer health products, today announced that Ms. Esther ... Conference, to be held at the Radisson Blu Edwardian Hotel, London Heathrow, on ...
(Date:8/27/2015)... ... 27, 2015 , ... "I need a little help supporting and stabilizing myself ... Camp Hill, Pa. "I developed this support handle to give me the extra little ... GRIP to provide a helping hand when stepping into or out of the tub ...
Breaking Medicine News(10 mins):Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:King Kullen Honors Their 85 Years of Success this August 2Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:Clinical Trial Supply Chain Logistics to be Discussed By Catalent Expert at Upcoming Flypharma Conference 2Health News:Inventor and InventHelp Client Develops Bathroom Stabilization Aid (LCC-432) 2
... vaccines for new flu strains, other health threats ... Researchers have devised a rapid and efficient method ... called monoclonal antibodies, which mark and neutralize foreign ... accelerate the traditionally challenging task of generating human ...
... Healed by Registered Organ and Tissue Donors, ... tissue donors joined organ transplant recipients at the ... the Department of Motor,Vehicles (DMV) and the three ... lives by signing up on the state-authorized Donate ...
... healthy,eating and neonatal jaundice are among the many topics ... the upcoming Pediatric,Academic Societies Meeting in Honolulu May 2-6. ... more information or to reach one of,the researchers, call ... **ALL RESEARCH IS EMBARGOED UNTIL THE DATE AND TIME ...
... JOLLA, CA Diabetic individuals have a significantly ... molecular connection between the two remains unexplained. Now, ... identified the probable molecular basis for the diabetes ... in the current online issue of Neurobiology of ...
... from Allscripts Document Management; Expects ... Clinical & Financial Investment, CHICAGO and FORT ... of clinical software, connectivity and,information solutions that physicians ... Center Medical Group has selected the Allscripts,Electronic Health ...
... Fall Out Boy, Will.i.am, Alyssa Milano, Say Anything,Perez ... Helping Fuel,Game,s Viral Spread, Developed in Partnership ... Personal Stories of Americans Living With and Without,HIV/AIDS, ... Peabody and,Emmy Award-winning college network, and the Kaiser ...
Cached Medicine News:Health News:Researchers Develop Quick Way to Create Human Antibodies 2Health News:Researchers Develop Quick Way to Create Human Antibodies 3Health News:Three Million Californians Say 'Yes!' to Organ and Tissue Donation 2Health News:Three Million Californians Say 'Yes!' to Organ and Tissue Donation 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 2Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 2Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 4Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 2Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 3Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 4Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 5Health News:mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS 6
The Aortic Root Cannulae With Vent Line are flanged, with radiopaque tips; two side holes in tip....
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
... Medtronic Select CAP® cannulae provides a ... pressure readings. An innovative combination of ... monitoring line, the Select CAP® can ... central arterial pressure readings on which ...
Intermittent catheter...
Medicine Products: